Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY

(MRK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck and Company
Merck and Company specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (73.4%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (16.1%);

- sale of animal health products (9.6%);

- other (0.9%).

Net sales are distributed geographically as follows: the United States (43.1%), Europe/Middle East/Africa (28.9%), Japan (7.6%), Asia/Pacific (12%), Latin America (5.7%) and other (2.7%).
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Pharmaceutical35,15189%35,39088.5% +0.68%
Other Segment3,8629.8%4,27210.7% +10.62%
Other794.002%460.001.2% -42.07%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States18,47846.8%17,42443.6% -5.7%
Europe, Middle East and Africa10,95327.7%11,47828.7% +4.79%
Asia Pacific3,9189.9%4,33710.8% +10.69%
Japan2,8467.2%3,1227.8% +9.7%
Latin America2,1555.5%2,3395.9% +8.54%
Other1,4573.7%1,4223.6% -2.4%
Managers
NameAgeSinceTitle
Kenneth Frazier641992Chairman, President & Chief Executive Officer
Robert M. Davis, MBA522014CFO & Executive Vice President-Global Services
Sandy Tremps-1988Vice President-R&D IT CIO
James H. Scholefield562018Chief Information & Digital Officer
Thomas Henry Glocer602007Independent Director
Rochelle B. Lazarus, MBA712004Independent Director
Leslie Brun672008Lead Independent Director
Carlos Eduardo Represas de Almeida732009Independent Director
Patricia Russo661995Independent Director
Wendell Weeks592004Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 3,570,683,143 2,558,497,329 71.7% 1,010,308,500 28.3% 71.7%
Shareholders
NameEquities%
The Vanguard Group, Inc. 198,913,850 7.65%
BlackRock Fund Advisors 121,324,470 4.67%
SSgA Funds Management, Inc. 112,856,389 4.34%
Capital Research & Management Co. (World Investors) 87,304,175 3.36%
Wellington Management Co. LLP 70,277,582 2.70%
T. Rowe Price Associates, Inc. (Investment Management) 50,282,410 1.93%
Capital Research & Management Co. (International Investors) 32,984,606 1.27%
Northern Trust Investments, Inc.(Investment Management) 31,545,848 1.21%
Geode Capital Management LLC 30,812,489 1.18%
Norges Bank Investment Management 28,383,467 1.09%
Holdings
NameEquities%Valuation
Sutro Biopharma Inc (STRO) 2,723,50911.9%24,566,051 USD
Kalvista Pharmaceuticals Inc (KALV) 1,070,5896.23%21,144,133 USD
Menlo Therapeutics Inc (MNLO) 1,243,1685.35%5,121,852 USD
OpGen Inc (OPGN) 216,5362.50%281,497 USD
Markets and indexes
- NYSE
- Main Market
- DJIA / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  MRK:US
- Reuters Code :  MRK.N
- Datastream Code :  U:MRK
Company contact information
Merck and Company
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey
États-Unis (les)

Phone : +1 908 423 1000
Fax : +1 908 735 1253
Internet : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck and Company
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MERCK AND COMPANY7.98%210 028
JOHNSON & JOHNSON1.34%341 878
ROCHE HOLDING LTD.12.28%234 825
PFIZER-15.62%203 709
NOVARTIS16.65%198 073
AMGEN-0.30%116 390
NOVO NORDISK AS13.01%116 389
ASTRAZENECA15.66%110 661
SANOFI4.53%108 909
ABBVIE-23.44%104 351
ELI LILLY AND COMPANY-4.83%100 817
GLAXOSMITHKLINE9.12%99 990
BRISTOL-MYERS SQUIBB COMPANY-4.83%80 921
CELGENE CORPORATION53.50%69 726
BAYER AG12.07%69 606
TAKEDA PHARMACEUTICAL CO LTD4.64%54 608
ALLERGAN PLC23.87%54 309
JIANGSU HENGRUI MEDICINE CO.49.00%49 700
DAIICHI SANKYO COMPANY, LIMITED104.15%41 605
CHUGAI PHARMACEUTICAL CO LTD23.62%37 994
ASTELLAS PHARMA INC10.72%27 174
Connections : Merck and Company
Columbia Business School
Rush University Medical Center
Cornerstone Christian Academy
Bombardier Mexico SA de CV
Latin American Business Council
The Cleveland Clinic Foundation
American Bar Association
The International Business Council
Gambro AB
BlueVoyant LLC
Blueteam Investor LLC
Advertising Women of New York
Verto Analytics, Inc.
SARR Group LLC
President's Export Council
NXT Capital LLC
Verto Analytics Oy
National Institute of Genomic Medicine
K2 Intelligence, Inc.
KKR Management LLC
Atlantic Council
The Economic Club of New York
Supreme Court of the United States
The Corning Museum of Glass
New York State Bar Association
Women's Forum, Inc.
Yale University
Direct Marketing Association, Inc.
Forum Mondial de L'Economie
The Committee of 200
The Library of Congress (District of Columbia)
American Academy of Arts & Sciences
European Business Leaders' Convention
The American Law Institute
Angelic Ventures LP
G100 Cos.
The Pennsylvania State University
Council on Foreign Relations, Inc.
NewYork-Presbyterian Hospital
Fundacion Mexicana Para La Salud AC
The Partnership for New York City
Weill Cornell Medical College
Lincoln Center for the Performing Arts, Inc.
Pharmaceutical Research & Manufacturers of America
World Wildlife Fund, Inc.
Arconic Defense, Inc.
CMI Marketing, Inc.
The Conference Board, Inc.
Lehigh University
United States Defense Business Board
Corning, Inc. Foundation
AdvaMedDx